Fig. 4
From: Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Study Duration by trial phase for NMEs only
Fig. 4 | Orphanet Journal of Rare Diseases
From: Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Study Duration by trial phase for NMEs only
Orphanet Journal of Rare Diseases